Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1984;6:689-699

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kleinjans, J. C.
Right arrow Articles by Struyker Boudier, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleinjans, J. C.
Right arrow Articles by Struyker Boudier, H. A.

Hypertension, Vol 6, 689-699, Copyright © 1984 by American Heart Association


ARTICLES

Hemodynamic characterization of hypertension induced by chronic intrarenal or intravenous infusion of norepinephrine in conscious rats

JC Kleinjans, JF Smits, H van Essen, CM Kasbergen and HA Struyker Boudier

The present study was designed to determine the hemodynamic changes underlying the hypertension induced by chronic intrarenal infusion of norepinephrine (NE) in conscious rats. NE was infused for a 5-day period intrarenally with osmotic minipumps via a chronic catheter in the right suprarenal artery at rates of 4 and 36 micrograms . kg-1 . hr- 1 or intravenously at a rate of 36 micrograms . kg-1 . hr-1. Control rats received a 1 microliter . hr-1 intrarenal infusion of pyrogen-free 0.9% NaCl. In separate experiments, short-term effects were measured continuously during a 22- to 24-hour intrarenal infusion of 4 and 36 micrograms NE . kg-1 . hr-1 or intravenous infusion of 36 micrograms NE . kg-1 . hr-1. Intrarenal infusion of NE produced a more pronounced long-term hypertensive effect than infusion of the same dose intravenously. This hypertension was characterized by a rapid and sustained increase in total peripheral resistance index (TPRI). Despite of the initial renal vasoconstriction, specifically produced during the first 24 hours of intrarenal NE application, cardiac index (CI) in parallel to stroke volume index (SVI) decreased significantly during intrarenal as well as during intravenous NE infusion. Furthermore, no signs of sodium retention were observed. Both rates of intrarenal NE infusion have been shown previously to produce a significant long-term increase in plasma potassium concentration, and the present study indicates that this is presumably the result of decreased urinary potassium output. It is concluded that chronic hypertension produced by intrarenal or intravenous infusion is not volume-dependent. The relatively greater increase in TPRI during intrarenal NE infusion is attributed to vascular wall receptor sensitization by increased plasma potassium levels resulting from effects of intrarenally present NE on tubular cation exchange mechanisms.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
V. H. Gattone II, T. M. Siqueira Jr, C. R. Powell, C. M. Trambaugh, J. E. Lingeman, and A. L. Shalhav
Contribution of Renal Innervation to Hypertension in Rat Autosomal Dominant Polycystic Kidney Disease
Experimental Biology and Medicine, August 1, 2008; 233(8): 952 - 957.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Grisk and R. Rettig
Interactions between the sympathetic nervous system and the kidneys in arterial hypertension
Cardiovasc Res, February 1, 2004; 61(2): 238 - 246.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Grisk, H.-J. Rose, G. Lorenz, and R. Rettig
Sympathetic-renal interaction in chronic arterial pressure control
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R441 - R450.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. R. Hermans, H. van Essen, H. A. J. Struijker-Boudier, R. M. Johnson, F. Theeuwes, and J. F. M. Smits
Pharmacokinetic Advantage of Intrapericardially Applied Substances in the Rat
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 672 - 678.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. F. Plato and J. L. Osborn
Chronic Renal Neuroadrenergic Hypertension Is Associated With Increased Renal Norepinephrine Sensitivity and Volume Contraction
Hypertension, December 1, 1996; 28(6): 1034 - 1040.
[Abstract] [Full Text]